{"pub": "marketwatch", "url": "https://wsj.com/articles/diagnoses-of-the-state-of-cancer-treatments-11570819925", "downloaded_at": "2019-10-11 19:46:10.574242+00:00", "title": "Diagnoses of the State of Cancer Treatments", "language": "en", "text": "As an early-cancer-detection researcher, I applaud Azra Raza\u2019s critique of the therapy-centric approach to cancer management (\u201cCancer Is Still Beating Us: We Need a New Start,\u201d Review, Oct. 5).\n\nThe benefits of early cancer detection are hardly a foregone conclusion. Statistics showing improved survival with early detection are skewed by lead-time bias: Starting the \u201csurvival clock\u201d earlier in the disease course will overestimate survival rates without changing disease mortality. There is also evidence that some cancers are...", "description": "A rational approach to early cancer detection could include focusing on individuals who have the highest genetic predisposition to cancer or tumor types with the longest lead times to metastasis.", "authors": [], "top_image": "https://si.wsj.net/public/resources/images/B3-FD197_FIRSTC_SOC_20191003111952.jpg", "published_at": "2019-10-11"}